PRESS RELEASE published on 01/09/2025 at 09:00, 1 year 3 months ago Important milestone for Biotest: Biologics License Application for Fibrinogen submitted to the US Food and Drug Administration (FDA) Biotest AG reaches a significant milestone by submitting a Biologics License Application for Fibrinogen to the US FDA, aiming to address fibrinogen deficiency FDA Biotest AG Fibrinogen Biologics License Application Medical Treatment
BRIEF published on 11/15/2024 at 09:05, 1 year 5 months ago Minister and Mayor Advocate for Plasma Donations at Biotest's Center Biotest AG Public Awareness Plasma Donations Darmstadt Healthcare Employment
BRIEF published on 11/15/2024 at 09:05, 1 year 5 months ago Le ministre et le maire plaident en faveur des dons de plasma au centre Biotest Biotest AG Sensibilisation Du Public Darmstadt Dons De Plasma Emploi Dans Le Secteur De La Santé
PRESS RELEASE published on 11/15/2024 at 09:00, 1 year 5 months ago Minister of Economic Affairs Mansoori and Lord Mayor Benz visit Biotest's plasma center in Darmstadt and call for plasma donations Minister of Economic Affairs Mansoori and Lord Mayor Benz visit Biotest's plasma center in Darmstadt to promote plasma donations and secure the long-term supply of plasma. Biotest AG emphasizes the importance of plasma donation in treating various illnesses Community Support Healthcare Biotest AG Plasma Donations Plasma Center
BRIEF published on 11/14/2024 at 10:19, 1 year 5 months ago Biotest Reports 4.5% Revenue Increase in First Nine Months of 2024 Financial Outlook Biotest Revenue Yimmugo® Growth Fibrinogen BT524 Grifols Agreement
BRIEF published on 11/14/2024 at 10:19, 1 year 5 months ago Biotest annonce une augmentation de son chiffre d'affaires de 4,5 % au cours des neuf premiers mois de 2024 Perspectives Financières Chiffre D'affaires De Biotest Croissance De Yimmugo® Fibrinogène BT524 Accord Grifols
PRESS RELEASE published on 11/14/2024 at 10:14, 1 year 5 months ago Biotest increases revenues in the first 9 months by 4.5% to Euro 523 million Biotest AG reports 4.5% revenue growth in first 9 months, reaching Euro 523 million. Product sales rise by 13.7%. Adjusted EBIT remains stable. Marketing authorization application submitted for Fibrinogen Concentrate (BT524). Outlook adjusted Revenue Growth EBIT Biotest AG Product Sales Marketing Authorization
BRIEF published on 11/14/2024 at 09:01, 1 year 5 months ago Biotest AG Revises Revenue, Cash Flow, and ROCE Forecasts for 2024 Revenue Growth Financial Forecast Biotest AG ROCE EBIT Guidance
BRIEF published on 11/14/2024 at 09:01, 1 year 5 months ago Biotest AG révise ses prévisions de revenus, de flux de trésorerie et de ROCE pour 2024 Biotest AG ROCE Prévisions Financières Croissance Des Revenus Prévisions EBIT
PRESS RELEASE published on 11/14/2024 at 08:56, 1 year 5 months ago EQS-Adhoc: Biotest AG: Biotest corrects forecast for revenue, cash flow and ROCE – EBIT guidance unchanged Biotest AG corrects forecast for revenue, cash flow, and ROCE while maintaining EBIT guidance. Details on the adjustments made for the 2024 financial year disclosed Revenue Cash Flow Biotest AG ROCE Forecast Correction
Published on 05/07/2026 at 16:35, 1 hour 28 minutes ago Caledonia Mining Corporation Plc New Corporate Video
Published on 05/07/2026 at 15:15, 2 hours 48 minutes ago ACCESS Newswire Launches ACCESS Insights & Analytics, AI-Powered Press Release Scoring Platform
Published on 05/07/2026 at 14:35, 3 hours 28 minutes ago Worksport (NASDAQ: WKSP) Announces Q1 2026 Earnings Call Date and Launch of Investor Townhall Series
Published on 05/07/2026 at 14:30, 3 hours 33 minutes ago Rio Grande Resources Announces Results of First Annual General Meeting and Re-Appointments
Published on 05/07/2026 at 14:30, 3 hours 33 minutes ago Loar Holdings Inc. Reports Q1 2026 Record Results and Upward Revision to 2026 Outlook
Published on 05/07/2026 at 17:45, 18 minutes ago Swiss Life shareholders approve all resolutions proposed by the Board of Directors
Published on 05/07/2026 at 17:45, 18 minutes ago Annual General Meeting of SKAN Group AG approves all proposals
Published on 05/07/2026 at 17:45, 18 minutes ago Results of Annual Shareholders Meeting of R&S Group Holding AG
Published on 05/07/2026 at 17:15, 48 minutes ago Porsche streamlines the Executive Board: Car IT to be part of Research & Development in the future
Published on 05/07/2026 at 17:45, 18 minutes ago INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 05/07/2026 at 17:45, 18 minutes ago INFORMATION MENSUELLE RELATIVE AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL
Published on 05/07/2026 at 17:45, 18 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL
Published on 05/07/2026 at 17:45, 18 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL